|Videos|May 25, 2022
Recent studies investigate Phexxi for various potential indications
Author(s)Morgan Ebert
Bassem Maximos, MD, MPH, FACOG, discusses 2 recent studies investigating nonhormomal contraceptive gel Phexxi (Evofem Biosciences) for the potential treatment of UTIs and improvement in sexual satisfaction.
Advertisement
**Editors note: In an earlier version of this video, Dr. Maximos explained that 77% of women on study/using Phexxi suffered a UTI. The data actually shows that 77 women out of 1339 study subjects suffered a UTI, a notable decrease in UTIs in women using Phexxi. The video has since been edited to reflect this correction.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG clinical update recommends salpingectomy at time of hysterectomy
2
Report: Postpartum depression market expected to grow based on awareness, pipeline progress
3
Recognizing signs of postpartum psychosis, with Alexis Totaro, MSN
4
Carrie Carda, MD, on peptide therapy for PMOS, endometriosis, and fertility
5